The importance of HIV cognitive impairment, including HIV associated dementia (HAD) and
minor cognitive/motor disorder, has continued in the era of highly active antiretroviral …

Despite the availability of highly active antiretroviral therapy (HAART), primary HIV-related
neurological diseases remain major problems in HIV clinics. The present review examines …

Despite the fact that neurons are rarely infected by the human immunodeficiency virus (HIV),
neuronal loss is common in patients with HIV infection, likely due to the effects of viral …

Important advances have been made in recent years in identifying the molecular
mechanisms of HIV neuropathogenesis. Defining the pathways leading to HIV dementia has …

Infection of the central nervous system by the type 1 human immunodeficiency virus (HIV-1)
commonly results in a number of neurological impairments known, in their most severe form …

The human immunodeficiency virus invades the central nervous system early after infection
where it later gives rise to cognitive, motor, and behavioral manifestations in children and …

Human immunodeficiency virus type 1 (HIV) infection presently affects more that 40 million
people worldwide, and is associated with central nervous system (CNS) disruption in at least …

The neuropathogenesis of HIV-1 infection of the central nervous system (CNS) has been
intensively studied, yet it remains incompletely understood. The virus enters the CNS early …

Remarkable progress was made in recent years in the therapeutics of HIV-1–associated
dementia (HAD) and in unraveling the complex pathophysiology that follows viral invasion of …

Abstract HIV Associated Dementia (HAD) and peripheral neuropathy result from HIV-1
infection and several parameters impact on their initiation and course. These parameters …